Conditioned Medium From MCF-7 Cell Line Induces Myofibroblast Differentiation, Decreased Cell Proliferation, and Increased Apoptosis in Cultured Normal Fibroblasts but not in Fibroblasts from Malignant Breast Tissue
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
We studied the effect of conditioned medium (CM) obtained from cultures of oestrogen-receptor positive breast cancer MCF7 cell line on the differentiation, proliferation and apoptosis patterns of cultured breast fibroblasts from normal interstitial and malignant stromal tissue. Fibroblasts were grown in the presence or absence of CM and examined for the differentiation pattern by immunofluorescence and Western blotting procedures, for proliferation profile by Ki67 expression, and for apoptosis by the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling technique. Monoclonal antibodies specific for non-muscle (NM), smooth muscle (SM) lineage and differentiation markers were applied to these cultures. CM is able to induce a SM-like differentiation in interstitial fibroblasts, i.e., essentially myofibroblast formation. Fibroblasts from tumour stroma showed the presence of a small number of smooth muscle cells (SMC) along with a large number of myofibroblasts. Treatment of these cultures with CM was unable to change this pattern. Only normal fibroblasts were responsive to the proliferation/apoptotic-inhibitory effect of the CM.
These data suggest that structural and functional differences exist between stromal fibroblasts from normal breast and breast cancer with respect to the responsiveness to soluble factors present in the CM. We hypothesize that the lack of in vitro sensitivity to CM shown by ‘tumour’ fibroblasts is the result of an in vivo inherent and stable phenotypic change on the fibroblasts surrounding breast tumour cells occurring via a paracrine mechanism.
- Adam PJ, Regan CP, Hautmann MB, Owens GK (2000) Positive and negative-acting Krüppel-like transcription factors bind a transforming growth factor )β control element required for expression of the smooth muscle cell differentiation marker SM22α in vivo. J Biol Chem 275: 37798–37806.
- Adam L, Crepin M, Lelong JC, Spanakis E, Israel L (1994) Selective interactions between mammary epithelial cells and fibroblasts in co-culture. Int J Cancer 59: 262–268.
- Arora PD, McCulloch CA (1999) The deletion of transforming growth factor-beta-induced myofibroblasts depends on growth conditions and actin organization. Am J Pathol 155: 2087–2099.
- Chiavegato A, Bochaton-Piallat ML, D'Amore E, Sartore S, Gabbiani G (1995) Expression of myosin heavy chain isoforms in mammary epithelial cells and in myofibroblasts from different fibrotic settings during neoplasia. Virchows Archiv 426: 77–86.
- Desmoulière A, Geinoz A, Gabbiani F, Gabbiani G (1993) Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122: 103–111.
- Dong-Le Bouhris X, Berthois Y, Millot G, Degeorges A, Sylvi M, Martin PM, Calvo F (1997) Effect of stromal and epithelial cells derived from normal and tumorous breast tissue on the proliferation of human breast cancer cell lines in co-culture. Int J Cancer 71: 42–48.
- Duband JL, Gimona M, Scatena M, Sartore S, Small JV (1990) Calponin and SM22 as differentiation markers of smooth muscle: spatiotemporal distribution during avian embryonic development. Differentiation 55: 1–11. Dublin EA, Barnes DM, Wang DY, King RJB, Levison DA (1993) TGF alpha and TGF beta expression in mammary carcinoma. J Pathol 170: 15–22.
- Emura M, Ochiai A, Horino M, Arndt W, Kamino K, Hiroashi S (2000) Development of myofibroblasts from human bone marrow mesenchymal stem cells cocultured with human colon carcinoma cells and TGF beta1. In Vitro Cell Dev Biol 36: 77–80.
- Faggin E, Puato M, Zardo L, Franch R, Millino C, Sarinella F, Pauletto P, Sartore S, Chiavegato A (1999) Smooth muscle-specific SM22 protein is expressed in the adventitial cells of balloon-injured rabbit carotid artery. Arterioscler Thromb Vasc Biol 19: 1393–1404.
- Frid MG, Printseva OY, Chiavegato A, Faggin E, Scatena M, Koteliansky VE, Pauletto P, Gluckova MA, Sartore S (1993) Myosin heavy chain isoform composition and distribution in developing and adult human aortic smooth muscle. J Vasc Res 30: 279–292.
- Gleizes P-E, Munger JS, Nunes I, Harpel JG, Mazzieri R, Noguera I, Rifkin DB (1997) TGF-β latency: biological significance and mechanisms of activation. Stem Cells 15: 190–197.
- Giuriato L, Scatena M, Chiavegato A, Tonello M, Scannapiego G, Pauletto P, Sartore S (1992) Non-muscle myosin isoforms and cell heterogeneity in developing rabbit vascular smooth muscle. J Cell Sci 101: 233–246.
- Gorsch SM, Memoli VA, Stukel TA, Gold LI, Arrick BA(1992) Immunohistochemical staining for transforming growth factor β1 associates with disease progression in human breast cancer. Cancer Res 52: 6949–6952.
- Gressner AM, Polzar B, Lahme B, Mannherz HG (1996) Induction of rat liver parenchymal cell apoptosis by hepatic myofibroblasts via transforming growth factor β. Hepatology 23: 571–581.
- Haslam SZ, Counterman LJ (1991) Mammary stroma modulates hormonal responsiveness of mammary epithelium in vivo in the mouse. Endocrinology 129: 2017–2023.
- Hautmann MB, Adam PJ, Owens GK (1999) Similarities and differences in smooth muscle α-actin induction by TGF-β in smooth muscle cells versus non-muscle smooth muscle cells. Arterioscler Thromb Vasc Biol 19: 2049–2058.
- Hornby AE, Cullen KJ (1995) In: Goldberg ID, Rosen EM, eds. Epithelial-Mesenchymal Interactions in Cancer. Switzerland: Birkhäuser Verlag, pp. 249–271.
- Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB (1987) Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48: 417–428.
- Koli KM, Arteaga CL (1996) Complex role of tumor cell transforming growth factor (TGF)-βs on breast carcinoma progression. J Mammary Gland Biol Neoplasia 1: 373–380.
- Lazard D, Sastre X, Frid MG, Gluckova MA, Thiery JP, Kotelianski VE (1993) Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci USA 90: 999–1003.
- McCune B, Mullin BR, Flanders KC, Jaffurs WJ, Mullen LT, Sporn MB (1992) Localization of transforming growth factor-β isotypes in lesions of the human breast. Hum Pathol 23: 13–20.
- Noel A, Munaut C, Nusgens C, Lapiere CM, Foidart JM (1993) Different mechanisms of extracellular matrix remodeling by fibroblasts in response to human mammary neoplastic cells. Invasion Metastasis 13: 72–81.
- Park CC, Bissel MJ, Barcellos-Hoff MH (2000) The influence of the microenvironment on the malignant phenotype. Mol Med Today 6: 324–329.
- Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB (1999) Myofibroblasts I. Paracrine cells important in health and disease. Am J Physiol 277(Cell Physiol 46): C1–C19.
- Roelofs M, Faggian M, Pampinella F, Paulon T, Franch R, Chiavegato A, Sartore S (1998) Transforming growth factor β1 involvement in the conversion of fibroblasts to smooth muscle cells in the rabbit bladder serosa. Histochem J 30: 393–404.
- Rønnov-Jessen L, Petersen OW, Bissel MJ (1996) Cellular changes involved in conversion of normal to malignant breast: importance of the stroma reaction. Physiol Rev 76: 69–125.
- Rønnov-Jessen L, Petersen OW, Kotelianski VE, Bissel MJ (1995) The origin of myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest 95: 859–873.
- Rønnov-Jessen L, Van Deurs B, Nielsen M, Petersen OW (1992) Identification, paracrine generation and possible function of human breast carcinoma myofibroblasts in culture. In Vitro Cell Dev Biol 28: 273–283.
- Sartore S, Chiavegato A, Franch R, Faggin E, Pauletto P (1997) Myosin gene expression and cell phenotypes in vascular smooth muscle during development, in experimental models and in vascular disease. Arterioscler Thromb Vasc Biol 17: 1210–1215.
- Sartore S, Franch R, Roelofs M, Chiavegato A (1999) Molecular and cellular phenotypes and their regulation in smooth muscle. Rev Physiol Biochem Pharmacol 134: 235–320.
- Schmitt-Grôff A, Gabbiani G (1992) Phenotypic features of stromal cells in normal, premalignant and malignant conditions. Eur J Cancer 28A: 1916–1992.
- Serini G, Gabbiani G (1999) Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res 250: 273–283.
- Shi Y, O'Brien E, Fard A, Zalewski A(1996)Transforming growth factor-β1 expression and myofibroblast formation during arterial repair. Arterioscler Thromb Vasc Biol 16: 1298–1305.
- Taipale J, Saharinen J, Keski-Oja J (1998) Extracellular matrixassociated transforming growth factor-β: Role in cancer cell growth and invasion. Adv Cancer Res 65: 86–124.
- Valverius EM, Ciardiello F, Heldin NE, Blondel B, Merlo G, Smith G, Stampfer MR, Lippman ME, Dickson RB, Salomon DS (1990) Stromal influences on transformation of human mammary epithelial cells overexpressing c-myc and SV-40T. J Cell Physiol 145: 207–216.
- Van Roozendaal KE, Klijn JG, van Ooijen B, Claassen C, Eggermont AM, Henzen-Logmans SC, Foekens JA (1996) Differential regulation of breast tumor cell proliferation by stromal fibroblasts of various breast tissue sources. Int J Cancer 65: 120–125.
- Conditioned Medium From MCF-7 Cell Line Induces Myofibroblast Differentiation, Decreased Cell Proliferation, and Increased Apoptosis in Cultured Normal Fibroblasts but not in Fibroblasts from Malignant Breast Tissue
The Histochemical Journal
Volume 33, Issue 9-10 , pp 499-509
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Oncology and Haematological Oncology, P.F. Calvi Hospital, L.go S. Giorgio 3, 30033, Noale, Venice, Italy
- 2. P.F. Calvi Hospital, L.go S. Giorgio 3, 30033, Noale, Venice, Italy; Author for correspondence
- 3. Department of Biomedical Sciences, University of Padua, Italy
- 4. Department of Pathology, General Hospital, Mirano, Venice, Italy
- 5. General Surgery Division, General Hospital, Mirano, Venice, Italy